Clinical Trial Update: A Clinical Trial to Evaluate the Efficacy and Safety of CKD-495 [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and safety of CKD-495 for gastritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastritis

Drugs mentioned

• CKD-495

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Gastritis | Phase 3 | Status: COMPLETED